Clarity
Clarity and insight into the MENA healthcare landscape, payer and access hurdles, and patient needs.
We understand — in fact, we live — the MENA healthcare landscape, market access hurdles, payer requirements, and patient needs.
Local insight.Global impact.
The Center of Clinical, Health Economics and Outcomes Research (CCHO) is a data-driven, relationship-focused and patient-centric consultancy dedicated to improving healthcare in the Middle East and North Africa (MENA). We specialize in pharmaceutical market access, real world evidence (RWE), and health economics and outcomes research (HEOR).
We are the only company that utilizes our proprietary unique business model, bolstered by nationally-recognized researchers, to address the MENA region’s most critical healthcare problems using evidence-based solutions.
Operating across the Middle East, combining local knowledge with 20 years of international expertise in the pharmaceutical industry and public health sector.
A multidisciplinary network of field specialists — leading policy analysts, economists, epidemiologists, clinicians and academics — dedicated to pharmaceutical market access, real world evidence and HEOR across MENA.
Learn moreAt CCHO, we live by the tagline “Local insight. Global impact.” For over 20 years, our network of highly-trained, regionally-recognized and multi-lingual researchers have worked to address the most pressing problems in MENA healthcare and pharmaceutical market access.
Meet the teamMarket Access success for the MENA region is CCHO’s guiding mission. We achieve this through the 4 Pillars of Clarity, Credibility, Connection and Collaboration.
Clarity and insight into the MENA healthcare landscape, payer and access hurdles, and patient needs.
We understand — in fact, we live — the MENA healthcare landscape, market access hurdles, payer requirements, and patient needs.
Unparalleled clarity of MENA market insight, robust methodologies, and understanding of key decision-makers.
Scientifically robust methodologies combined with a deep understanding of clinicians, payers, patients and policy-makers.
Deepest and most diverse stakeholder network in the Middle East and North Africa.
Exceptional connections with payers, academic institutions, healthcare systems, policymakers and patient advocacy organizations.
A proprietary Research Partnership Methodology that drives successful and sustainable relationships.
A scientific-method approach to collaboration that respects cultural, individual and business boundaries.
We solve your value, evidence, and access challenges by leveraging our exceptional insight and experience, a proprietary business model, and a vast network of highly-trained, regionally-recognized and multi-lingual researchers with decades of experience in the Middle East and North Africa.
Every project deserves a white-gloved bespoke approach to ensure that your unique business challenges are addressed.
Evidence generated from MENA practice settings to support value and access decisions.
Learn morePROMs and PREMs consulting, development, validation and Arabic cultural adaptation.
Learn moreLaunch readiness, pricing and reimbursement strategy, managed entry agreements.
Learn moreCost-effectiveness, budget impact and burden-of-disease studies for MENA systems.
Learn moreExpert-led HEOR, HTA and market access workshops in English, French and Arabic.
Learn moreRegulatory submissions, value dossiers, scientific publications and communications.
Learn morePrimary stakeholder research, advisory boards and engagement strategy.
Learn moreSee how they combine for your programme.
All solutionsWorking with universities, ministries and payers to build the evidence base for healthcare decisions in the region.
The first hybrid university diploma in Health Economics and Outcomes Research designed for the MENA region — 36 credits, 6 courses over 10 months, for working professionals anywhere in the world.
Read moreDeveloping a value set for EQ-5D-5L health states based on the preferences of the UAE general population — 1,150 face-to-face interviews following the EuroQol valuation protocol.
Read moreBlog · Events & webinars. How PROs bring the patient’s perspective into treatment decisions, measurement properties of PRO measures, and their place in Saudi Vision 2030.
Read the articleTwo abstracts, developed in collaboration with healthcare leaders from the Ministries of Health of Saudi Arabia and Iraq, accepted for presentation at ISPOR Europe 2024.
Read the latest editionIf you are passionate about Health Economics and Outcomes Research, apply to join our team. We give purpose to each project, and live by the 4 pillars that define us.
Join our talentTell us about your value, evidence and access challenge in the MENA region and we will come back to you within two business days.
